Navigation Links
Pradaxa Internal Bleeding Claims Are Now Being Reviewed by Resource4thePeople Attorneys
Date:3/9/2013

San Diego, CA (PRWEB) March 09, 2013

http://www.resource4thepeople.com/defectivedrugs/pradaxa-lawsuits.html

Resource4thePeople announced today that its attorneys are now investigating claims from victims who allegedly may have suffered serious health problems as a result of their use of the popular blood thinner Pradaxa.

“Our lawyers are now actively investigating these claims and stand ready to provide consultations in which the legal options available to seek compensation in such cases can be provided to consumers,” said Resource4thePeople.

“We are now reviewing these claims as a result of the increasing number of inquiries from consumers about their legal rights in connection with serious health side effects such as internal bleeding that may have occurred as a result of using the medication Pradaxa."

Resource4thePeople notes that the increasing number of Pradaxa lawsuits being filed has caused the federal court system to create what is called a multidistrict litigation* in which cases from across the country are being consolidated.

"We will be informing consumers about whether they may be eligible to join in this multidistrict litigation which is now under the supervision of a single judge in Illinois," said Resource4thePeople.

In such cases victims are allowed to file allegations through which they may seek compensation for wrongful deaths, medical costs, pain and suffering and other expenses if they can prove their claims.

Multidistrict litigations are so designated by the federal court system when a large number of cases involving similar allegations are brought under the supervision of a single judge for pre-trial evidence gathering and other legal procedures.

That judge may set bellwether trials, in which both plaintiffs' and defendants' lawyers test the strengths and weaknesses of their cases, and may also eventually designated the litigation as a massive class-action.

"One of the inquiries we are repeatedly receiving is whether it is to late to file a lawsuit that could be part of this multi-district litigation," said Resource4thePeople. "The answer, in the overwhelming number of cases, is no."

"The federal judge in the case has not issued any order prohibiting additional claims being filed and, in his most recent ruling, found that plaintiffs' lawyers will be granted access to documents they were seeking, which means there will still be additional time before any trial is held."

U.S. District Court Judge David R. Herndon granted the request to victims’ lawyers in the multidistrict litigation seeking access to a case settled by Pradaxa manufacturer Boehringer Ingelheim last year.

Judge Herndon’s ruling against Boehringer Ingelheim involved a $95 million settlement over the company’s marketing campaign to promote Pradaxa.

The current litigation before Herndon involves allegations that Pradaxa can cause serious internal bleeding problems which can lead to heart attacks and brain hemorrhages.*

Herndon has scheduled the first bellwether trials in the Pradaxa litigation to start in August, 2014.

Boehringer Ingelheim has denied the claims that have been filed against them in the Pradaxa litigation, including allegations that the company was negligent by failing to adequately warn health care professionals and patients about bleeding side effects.*

According to allegations in the Pradaxa multi-district litigation, the drug was approved by the FDA in 2010 as an improvement over another blood-thinner, warfarin, for patients vulnerable to atrial fibrillation.

Plaintiffs in the Pradaxa multi-district litigation are claiming that in cases of internal bleeding there is an antidote for warfarin but there is no antidote for Pradaxa and that in some cases deaths have occurred.

There are currently over 150 lawsuits in the multi-district litigation before Judge Herndon and Bloomberg News recently reported that Pradaxa “has been linked to more than 500 U.S. deaths over a two-year period.”**

Bloomberg also reported that “Concerns about Pradaxa’s safety surfaced soon after U.S. doctors began prescribing it. FDA officials said they received reports of 542 deaths and 3,781 side-effect incidents tied to the drug in 2011.”**

Resource4thePeople also is advising consumers who may have been or are being treated with Pradaxa that the FDA recently issued a Drug Safety Communication warning that the medication should not be used in patients with mechanical prosthetic heart valves.***

In the communication the FDA also noted a previously released Drug Safety Communication about the risk of serious bleeding associated with the use of Pradaxa in patients with non-valvular atrial fibrillation, the population for which the drug is approved.

Sources:

  • MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, U.S. District Court, Southern District of Illinois
** http://www.bloomberg.com/news/2012-12-11/boehringer-sued-by-hundreds-over-bleeding-tied-to-pradaxa.html
***http://www.fda.gov/Drugs/DrugSafety/DrugSafetyPodcasts/ucm333209.htm

Read the full story at http://www.prweb.com/releases/2013/3/prweb10509279.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. d’Oliveira & Associates Releases New Webpage on Pradaxa Lawsuits
2. Pradaxa Lawsuits: Bernstein Liebhard LLP Notes Upcoming Status Conference in Federal Pradaxa Litigation
3. DrugRisk Pradaxa Update: Litigation Grows As New Study Adds to Risks
4. Pradaxa Lawsuits: Bernstein Liebhard LLP Notes Upcoming Status Conference in Federal Pradaxa Litigation
5. DrugRisk Pradaxa Lawsuit Update: Court Denys Boehringer’s Protective Order Request
6. DrugRisk Update: Court Allows Charges of Prior Fraud Into Pradaxa Lawsuit
7. Bernstein Liebhard LLP Launches Pradaxa Lawsuit Website Providing Information on Mounting Pradaxa Litigation, Side Effects
8. Pradaxa Side Effect Problems Continue, as New Report Finds Pradaxa Bleeding More Likely to Result in Death, Bernstein Liebhard LLP Reports
9. 176 Pradaxa Lawsuits Now Pending in Federal Litigation, Discovery Well Underway, Bernstein Liebhard LLP Reports
10. DrugRisk Announces New Pradaxa Health Warning From Australia
11. Pradaxa Lawsuits Being Investigated by Bernstein Liebhard LLP, as Next Conference in Federal Pradaxa Litigation Set for January 10th
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... (PRWEB) , ... April 26, ... ... which provides an agile ecosystem and domain expertise for sponsors and CROs ... randomization and trial supply management (RTSM) software platform. Bioclinica AGILE RTSM ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... Newport Beach, California, committed to raising awareness for Duchenne muscular dystrophy, and ... its randomized CAP-1002 (cardiosphere-derived cells) Phase I/II HOPE clinical trial in Duchenne ...
(Date:4/25/2017)... ... ... Lake Park Dental is now accepting new patients with crooked teeth who ... the help of this highly-effective, yet convenient system, patients can straighten their teeth and ... pain. , Drs. Sarah Jockin, Nicole Morganti, Sara Spear and Elizabeth Dy, of ...
(Date:4/25/2017)... ... 2017 , ... Buyers and sellers in the thriving multi-billion dollar cannabis marketplace ... help but be heartened by the industry’s current surge. But another thing that unifies ... smell.” At last they can simply, safely and effectively end their aroma anguish ...
(Date:4/25/2017)... ... April 25, 2017 , ... Vetoquinol USA® ... introducing Flexadin UCII, part of the EQUISTRO line, at this week’s Rolex Kentucky ... horses at the immunologic level. , The scientifically-developed Flexadin UCII supports the body’s ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... 2017 Research and Markets has announced ... Services Market Analysis By Service (Manufacturing, Research), By Country, (Brazil, ... 2025" report to their offering. ... The Latin American pharmaceutical contract manufacturing services ... Low drug registration cost in Latin American countries ...
(Date:4/19/2017)... , April 19, 2017 The Mobile X-Ray ... showcase a healthy CAGR during the forecast period ... in the global digital mobile X-Ray devices market, which is ... in 2017, expanding at a CAGR of 7% over the ... $ opportunity of more than US$ 100 Mn in 2017 ...
(Date:4/19/2017)... April 19, 2017 Global Prostate Cancer ... on the prostate cancer therapeutics market analyzes the ... Increasing prevalence of prostate cancer, launch of promising ... development of new drugs & therapeutic biological products, ... due to lesser side effects are some of ...
Breaking Medicine Technology: